Evaluation of Antimicrobial, Antiadhesive and Co-Aggregation Activity of a Multi-Strain Probiotic Composition against Different Urogenital Pathogens
2023
International Journal o f Molecular Sciences | SynBalance srl, Origgio, VA, Italy - VitroScreen srl, Milan, MI, Italy - Complife Italia srl, Garbagnate Milanese, MI, Italy - Roelmi HPC srl, Origgio, VA, Italy
Comparison of the metabolism of 10 cosmetics-relevant chemicals in EpiSkin™ S9 subcellular fractions and in vitro human skin explants
2019
Journal of Applied Toxicology | 1 Pierre Fabre Dermo-Cosmétique, Toulouse, France - 2 Coty, Darmstadt, Germany - 3 The Procter & Gamble Company, Ohio, Cincinnati, USA - 4 Unilever, Sharnbrook, UK - 5 Beiersdorf AG, Hamburg, Germany - 6 Cosmetics Europe, Brussels, Belgium - 7 L'Oreal, Aulnay-Sous-Bois, France
Malassezia clinical isolates behavior on a reconstructed human epidermis
2019
Micoses, 2019 Oct;62(10):932-936. doi: 10.1111/myc.12965. Epub 2019 Jul 29. | University of Porto, Porto, Portugal, Centro Hospitalar S.João EPE, Porto, Portugal, Center for Health Technology and Services Research, University of Porto, Porto, Portugal, Episkin Academy, Lyon, France, Cardiovascular R&D Centre, Faculty of Medicine, University of Porto, Porto, Portugal 6 Burn Unit, Department of Plastic and Reconstructive Surgery, Centro Hospitalar S.João EPE, Porto, Portugal
An in vitro model to evaluate the impact of environmental fine particles on skin damage
2019
Elsevier - Toxicology Letters 305 (2019) 94-102 | Unité de Chimie Environnementale et Interactions sur le Vivant EA4492, SFR Condorcet FR CNRS 3417, Université du Littoral Côte d’Opale, 59140, Dunkerque, France; Centre Commun de Mesures (CCM), Université du Littoral Côte d’Opale, 59140, Dunkerque, France; Laboratoires Clarins, 95300, Pontoise, France; INSERM UMR 1153 - CRESS, HERA (Health Environmental Risk Assessment) Research Unit, Paris Descartes-Sorbonne Paris Cité University, Paris, France; AP-HP Hôpital Bichat, Laboratoire de Biochimie, 75018, Paris, France
Adding the immune component in reconstructed human skin and eye epithelia models
2018
Poster Asiatox | EPISKIN Academy, Lyon, France - DBV Technologies, Bagneux, France - Vitroscreen, Milan, Italy - GSK, Les ullis, France
Cellular mechanistic investigation on antigen delivery by Viaskin® patchfor epicutaneous immunotherapy with reconstructed human epidermisincluding Langerhans cells (SkinEthicTM RHE-LC)
2018
Poster | DBV Technologies, Montrouge, France - Episkin, Lyon, France
Implementation, availability and regulatory status of an OECD accepted Reconstructed Human Epidermis model in Brazil
2018
Vigil. sanit. debate 2018;6(1):64-71 | L'Oréal, EPISKIN
Preclinical Evaluation of Tolerability of a Selective, Bacteriostatic, Locally Active Vaginal Formulation
2016
ELSEVIER | Effik Italia S.p.A.,Cinisello Balsamo, Italy & VitroScreen Srl, Milan, Italy & Studio Brugali Food & Chemical Consulting, Almenno S. Salvatore,Italy & Laboratory of Toxicology, DiSFeB, Università degli Studidi Milano, Milan, Italy
Effect of Repeated Daily Dosing with 2,4-Dinitrochlorobenzene on Glutathione Biosynthesis and Nrf2 Activation in Reconstructed Human Epidermis
2016
SOT Society of Toxicology | Unilever
Xenobiotic metabolizing enzymes in human skin and SkinEthic reconstructed human skin models
2015
Experimental Dermatology | L'Oréal Research & Innovation, France - Newcastle University, Newcastle upon, Tyne, UK
Comparison of xenobiotic metabolizing enzyme activities in ex vivo human skin and reconstructed human skin models from SkinEthic.
2014
Archives of Toxicology. 2014, March 22 | L'Oréal, Research & Innovation
Characterization of peroxidase activities in normal human skin compared with reconstructed human skin models
2013
Society of Toxicology (SOT) Annual meeting |
L’Oréal commitment in the develo pment, evaluation and validation of screening and testing approaches contributing to the 3Rs
2011
| L'Oréal
Cutaneous Metabolism
2011
| L'Oreal
Expression profiles of phases 1 and 2 metabolizing enzymes in human skin and the reconstructed skin models EpiskinTM and full thickness model from EpiskinTM
2009
Elsevier Journal of Steroid Biochemistry and Molecular Biology | L'Oréal, Episkin, SkinEthic
Expression profiles of phases 1 and 2 metabolizing enzymes in human skin and the reconstructed skin models Episkin and full thickness model from Episkin.
2009
J Steroid Biochem Mol Biol. 2009 Sep;116(3-5):178-86 | L'Oréal, Research & Innovation
Reconstructed skin for in vitro cutaneous pharmacotoxicology: Example of metabolic studies
1997
IN VITRO TOXICOL J MOL CELL TOXICOL. In Vitro Toxicology: Journal of Molecular and Cellular Toxicology 1997 ;10 (1):3-9 | R. Roguet, Life Sciences, L'Oreal Advanced Res. Laboratories, 1 Avenue E. Schueller, 93600 Aulnay sous Bois
Cytochrome P450-dependent enzyme activities and testosterone metabolism in a reconstituted human epidermis
1995
In Vitro Toxicology: Journal of Molecular and Cellular Toxicology 1995 ;8 (1):97-104 | L'Oreal, Dept Central Securite Produits, 1, Avenue Eugene Schueller,93600 Aulnay sous Bois
Characterization of skin reconstructed on a chitosan-cross-linked collagen-glycosaminoglycan matrix
1990
Skin Pharmacology 1990 ;3 (2):107-114 | Laboratoire de Substituts Cutanes (CNRS-URA 1341), Hopital Edouard Herriot, Pavillon 15, Place Arsonval, F-69437 Lyon
Reconstituted epidermis: a novel model for the study of drug metabolism in human epidermis
1990
J Invest Dermatol 1990 ;94 (6):749-52 | Centre du Medicament Nancy, France.